SODIUM HYDROXIDE
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 1310732
- UNII
- 55X04QC32I
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Functions of Sodium Hydroxide
| Bc - Boiler compound |
| B&n - Buffer & neutralizing agent |
| Misc - Miscellaneous |
Regulatory Status of Sodium Hydroxide
| Reg - Food additives for which a petition has been filed and a regulation issued. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Intrathecal | Injection | |
| An,cnblk Intrathecal | Injection | |
| An,infiltration | Injection | 0.07% |
| An,sympathetic Nblk | Injection | |
| Auricular (otic) | Solution | 0.8% |
| Auricular (otic) | Solution, Drops | |
| Auricular (otic) | Suspension | |
| Buccal | Film | 0.09MG |
| Buccal | Film, Soluble | 1.18MG |
| Caudal Block | Injection | |
| Dental | Injectable | |
| Dental | Injection | |
| Dental | Paste | |
| Dental | Solution | |
| Epidural | Injection | |
| Epidural | Solution, Injection | |
| Extracorporeal | Injection | |
| Extracorporeal | Solution | |
| Im - Iv | Injectable | |
| Im - Iv | Injection, Solution | |
| Im - Iv | Liquid, Water, Sterile, For Injection | |
| Im - Iv | Powder | |
| Im - Iv | Powder, For Injection Solution | 0.7% |
| Im - Iv | Powder, For Injection Solution, Lyophilized | |
| Im - Iv | Solution, Injection | |
| Im - Iv - Sc | Injection | |
| Im - Iv - Sc | Powder, For Injection Solution | |
| Im - Iv - Sc | Powder, For Injection Solution, Lyophilized | |
| Im - Iv - Sc | Solution, Injection | |
| Im - Sc | Injection | |
| Im - Sc | Injection, Sustained Action | |
| Im - Sc | Powder, For Injection Solution | |
| Infiltration | Injection | |
| Infiltration | Solution, Injection | |
| Inhalation | Aerosol, Metered | |
| Inhalation | Solution | 8% |
| Interstitial | Injection | |
| Intra-Amniotic | Injection | |
| Intra-Arterial | Injectable | |
| Intra-Arterial | Injection | |
| Intra-Arterial | Powder, For Injection Solution | |
| Intra-Arterial | Powder, For Injection Solution, Lyophilized | |
| Intra-Arterial | Solution, Injection | |
| Intra-Articular | Injectable | |
| Intra-Articular | Injection | |
| Intra-Articular | Injection, Sustained Action | |
| Intrabursal | Injection | |
| Intracardiac | Injection | |
| Intracaudal | Injection | |
| Intracavitary | Injection | |
| Intracavitary | Powder, For Injection Solution, Lyophilized | |
| Intradermal | Injection | |
| Intradermal | Injection, Sustained Action | |
| Intradermal | Powder, For Injection Solution | |
| Intradiscal | Powder, For Injection Solution | |
| Intralesional | Injectable | |
| Intralesional | Injection | |
| Intralesional | Injection, Sustained Action | |
| Intralesional | Suspension, Injection | |
| Intramuscular | Injectable | |
| Intramuscular | Injection | 3.15% |
| Intramuscular | Injection, Sustained Action | |
| Intramuscular | Liquid | |
| Intramuscular | Powder, For Injection Solution | |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 0.04%W/V |
| Intramuscular | Solution, Injection | |
| Intramuscular | Suspension, Extended Release | 0.54% |
| Intramuscular | Suspension, Injection | 0.28%W/V |
| Intraocular | Solution | |
| Intraperitoneal | Injection | |
| Intraperitoneal | Solution | |
| Intrapleural | Injection | |
| Intraspinal | Injection | |
| Intrasynovial | Injection | |
| Intrasynovial | Injection, Sustained Action | |
| Intrasynovial | Suspension, Injection | |
| Intrathecal | Injectable | |
| Intrathecal | Powder, For Injection Solution | |
| Intrathecal | Powder, For Injection Solution, Lyophilized | |
| Intrathecal | Solution | |
| Intrathecal | Solution, Injection | |
| Intratracheal | Injection | |
| Intratracheal | Powder, For Suspension | |
| Intratracheal | Suspension | |
| Intratumor | Injectable | |
| Intratumor | Injection | |
| Intratumor | Powder, For Injection Solution | |
| Intrauterine | Injection | |
| Intravascular | Injection | |
| Intravascular | Solution | |
| Intravascular | Solution, Injection | |
| Intravenous | Emulsion, Injection | |
| Intravenous | Injectable | 0.6% |
| Intravenous | Injection, Powder, Lyophilized, For Liposomal Suspension | |
| Intravenous | Injection, Solution | |
| Intravenous | Injection, Suspension | |
| Intravenous | Injection, Suspension, Liposomal | |
| Intravenous | Liquid | |
| Intravenous | Liquid, Water, Sterile, For Injection | |
| Intravenous | Powder, For Injection Solution | 13.66% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 19.27% |
| Intravenous | Solution | |
| Intravenous | Solution, Injection | 0.09% |
| Intravenous | Solution, Liposome, Injection | |
| Intravesical | Solution, Injection | |
| Intravitreal | Injectable | |
| Intravitreal | Injection | |
| Intravitreal | Suspension, Injection | |
| Iontophoresis | Drug Delivery System | 4.2MG |
| Iontophoresis | Solution | |
| Irrigation | Solution | |
| Iv - Sc | Powder, For Injection Solution | |
| Iv - Sc | Solution, Injection | |
| Iv(infusion) | Emulsion, Injection | |
| Iv(infusion) | Infusion | |
| Iv(infusion) | Injectable | |
| Iv(infusion) | Injection, Liposomal | |
| Iv(infusion) | Powder, For Injection Solution | 9% |
| Iv(infusion) | Powder, For Injection Solution, Lyophilized | 1.57% |
| Iv(infusion) | Solution | |
| Iv(infusion) | Solution, Injection | 2.83% |
| Nasal | Solution | |
| Nasal | Solution, For Inhalation | |
| Nasal | Solution, Spray | |
| Nasal | Spray | |
| Nasal | Spray, Metered | 0.004% |
| Nerve Block | Injection | 0.07% |
| Nerve Block | Solution, Injection | |
| Ophthalmic | Drops | |
| Ophthalmic | Emulsion | 0.4% |
| Ophthalmic | Gel | 1.69% |
| Ophthalmic | Powder, For Solution | |
| Ophthalmic | Solution | 0.1% |
| Ophthalmic | Solution, Drops | |
| Ophthalmic | Solution, Irrigation | |
| Ophthalmic | Suspension | |
| Ophthalmic | Suspension, Drops | |
| Oral | Capsule | 0.74MG |
| Oral | Capsule, Coated Pellets | 0.01MG |
| Oral | Capsule, Delayed Action | 0.01MG |
| Oral | Capsule, Enteric Coated Pellets | 0.08MG |
| Oral | Capsule, Soft Gelatin Liquid-Filled | 1.5MG |
| Oral | Concentrate | 0.2% |
| Oral | Emulsion | |
| Oral | Film, Soluble | 1.84MG |
| Oral | Granule, For Oral Suspension | |
| Oral | Liquid | 0.04% |
| Oral | Powder, For Oral Suspension | 0.09%W/W |
| Oral | Powder, For Solution | |
| Oral | Solution | 8% |
| Oral | Solution, Elixir | |
| Oral | Suspension | 8% |
| Oral | Syrup | 1.42% |
| Oral | Tablet | 6.72MG |
| Oral | Tablet, Coated | |
| Oral | Tablet, Delayed Action | 1.24MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 0.32MG |
| Oral | Tablet, Delayed Release | 0.04MG |
| Oral | Tablet, Extended Release | 5.33MG |
| Oral | Tablet, Orally Disintegrating | 0.16MG |
| Oral | Tablet, Sustained Action | 0.4MG |
| Parenteral | Injection | |
| Parenteral | Powder, For Injection Solution | |
| Perfusion, Cardiac | Solution | |
| Peridural | Injection | |
| Perineural | Injection | |
| Photopheresis | Solution | |
| Rectal | Enema | 0.44% |
| Rectal | Powder, For Injection Solution | |
| Rectal | Solution | 0.63% |
| Respiratory (inhalation) | Powder, For Inhalation | |
| Respiratory (inhalation) | Solution | |
| Respiratory (inhalation) | Solution, Aerosol, For Inhalation | |
| Respiratory (inhalation) | Solution, For Inhalation | 0.06% |
| Respiratory (inhalation) | Solution, Injection | |
| Retrobulbar | Injection | |
| Route Not Given | Dosage Form Not Given | |
| Soft Tissue | Injectable | |
| Soft Tissue | Injection | |
| Soft Tissue | Injection, Sustained Action | |
| Soft Tissue | Suspension, Injection | |
| Spinal | Injection | |
| Subarachnoid | Solution, Injection | |
| Subconjunctival | Injection | |
| Subcutaneous | Injectable | 0.42% |
| Subcutaneous | Injection | 3.15% |
| Subcutaneous | Injection, Solution | |
| Subcutaneous | Powder, For Injection Solution | |
| Subcutaneous | Powder, For Injection Solution, Lyophilized | |
| Subcutaneous | Powder, For Injection Solution, Lyophilized, With Additives | |
| Subcutaneous | Solution, Injection | 1% |
| Subcutaneous | Suspension | |
| Subcutaneous | Suspension, Injection | 0.07% |
| Submucosal | Solution, Injection | |
| Topical | Cream, Augmented | 2.72% |
| Topical | Cream, Emulsion, Sustained Release | 2.72% |
| Topical | Disc | |
| Topical | Emulsion | 0.2% |
| Topical | Emulsion, Cream | 0.52% |
| Topical | Emulsion, Lotion | 0.02% |
| Topical | Gel | 3.2% |
| Topical | Jelly | |
| Topical | Lotion | 2.6% |
| Topical | Lotion, Augmented | |
| Topical | Ointment | |
| Topical | Ointment, Augmented | 0.11% |
| Topical | Shampoo | |
| Topical | Solution | 0.01%W/V |
| Topical | Solution, Drops | |
| Topical | Sponge | |
| Topical | Suspension | |
| Topical | Swab | |
| Transdermal | Drug Delivery System | 4.2MG |
| Transdermal | Film, Controlled Release | 0.85MG |
| Transdermal | Gel | 7% |
| Ureteral | Solution | |
| Urethral | Solution | |
| Vaginal | Cream, Emulsion, Sustained Release | 0.03% |
| Vaginal | Emulsion, Cream | 0.19% |
| Vaginal | Gel | 0.25% |